4.7 Review

Bile liquid biopsy in biliary tract cancer

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Molecular diagnosis of pancreatobiliary tract cancer by detecting mutations and methylation changes in bile samples

Shun He et al.

Summary: BileScreen is a highly sensitive detection method based on bile samples, which can aid in the diagnosis of pancreatobiliary tract cancer. By parallel sequencing mutation and methylation changes, it demonstrates high accuracy and specificity. It shows promising results in three cohorts, especially in terms of specificity. This study provides a new option for the early diagnosis of pancreatobiliary tract cancer.

ECLINICALMEDICINE (2023)

Article Gastroenterology & Hepatology

Bile exosomal miR-182/183-5p increases cholangiocarcinoma stemness and progression by targeting HPGD and increasing PGE2 generation

Lizhuang Shu et al.

Summary: The study reveals the importance of bile exosomal miR-182/183-5p and the interaction between biliary epithelium and CCA cells in the progression of cholangiocarcinoma.

HEPATOLOGY (2023)

Article Chemistry, Multidisciplinary

Construction of Exosome SORL1 Detection Platform Based on 3D Porous Microfluidic Chip and its Application in Early Diagnosis of Colorectal Cancer

Peilong Li et al.

Summary: In this study, a 3D porous sponge microfluidic chip with an exosome enrichment platform was constructed, achieving a capture efficiency of approximately 90%. A specific exosome membrane protein (SORL1) for colorectal cancer was identified through deep mass spectrometry analysis, and a specific quantum dot labeling method for SORL1 detection was developed. An ensemble classification system was established using features extracted from 64-patched fluorescence images, and it showed a significantly higher area under the curve (AUC) of 0.99 compared to the conventional biomarker carcinoembryonic antigen (CEA) with an AUC of 0.71. This system demonstrated similar diagnostic performance for early-stage CRC, young CRC, and CEA-negative CRC patients.

SMALL (2023)

Article Multidisciplinary Sciences

Bile metabolites as diagnostic biomarkers for perihilar cholangiocarcinoma

DengYong Zhang et al.

Summary: Analysis of bile in the microenvironment of perihilar cholangiocarcinoma (pCCA) using metabolomics and statistical methods can aid in clinical diagnosis. A study collected clinical information and bile samples from patients with pCCA and gallstones, analyzing the bile samples with untargeted metabolomics methods. Through multivariate and univariate analyses, potential differential metabolites were screened and changes in the pCCA pathway and therapeutic targets were explored. Significant differences were found in blood indicators between the two groups, and a significant correlation was observed between clinical parameters and certain metabolites in the metabolic group. The study suggests that bile untargeted metabolomics combined with statistical analysis techniques can be used for the diagnosis and treatment of pCCA.

SCIENTIFIC REPORTS (2023)

Article Gastroenterology & Hepatology

Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma

Ainhoa Lapitz et al.

Summary: Protein biomarkers for the diagnosis and prognosis of cholangiocarcinoma (CCA) were found in serum extracellular vesicles (EVs), providing important information for individuals at high-risk, such as those with primary sclerosing cholangitis (PSC).

JOURNAL OF HEPATOLOGY (2023)

Article Biophysics

An immuno-magnetophoresis-based microfluidic chip to isolate and detect HER2-Positive cancer-derived exosomes via multiple separation

Byeonggeol Mun et al.

Summary: Microfluidic chip-based magnetically labeled exosome isolation system (MEIS-chip) efficiently separates HER2-positive cancer-derived exosomes from common exosomes, enabling cancer diagnosis and monitoring.

BIOSENSORS & BIOELECTRONICS (2023)

Review Biochemistry & Molecular Biology

Metabolomic Fingerprinting for the Detection of Early-Stage Lung Cancer: From the Genome to the Metabolome

Jean-Francois Haince et al.

Summary: The five-year survival rate of lung cancer patients is low due to late-stage diagnosis, emphasizing the importance of early detection. This review discusses various early detection methods such as chest X-rays, bronchoscopy, sputum analysis, and low-dose computed tomography (LDCT). It also highlights the potential of metabolomic fingerprinting as a cost-effective and accessible blood-based test for early-stage lung cancer screening.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Gastroenterology & Hepatology

Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry

Laura Izquierdo-Sanchez et al.

Summary: This study investigates the clinical course of cholangiocarcinoma in a pan-European cohort and finds that the disease is frequently diagnosed at an advanced stage and a proportion of patients fail to receive cancer-specific therapies, resulting in a poor prognosis.

JOURNAL OF HEPATOLOGY (2022)

Review Biochemistry & Molecular Biology

Exosomes as a new frontier of cancer liquid biopsy

Dan Yu et al.

Summary: Liquid biopsy, a revolutionary strategy for cancer diagnosis and prognosis prediction, uses minimally invasive detection through biofluids such as blood, saliva, and urine. Exosomes, a subset of extracellular vesicles, play a crucial role in intercellular communication and are considered as potential biomarkers in liquid biopsy. However, the lack of high-quality separation and component analysis methods has limited the further clinical application of exosomes.

MOLECULAR CANCER (2022)

Review Biochemistry & Molecular Biology

Proteomics technologies for cancer liquid biopsies

Zhiyong Ding et al.

Summary: The complexity of proteomes in liquid biopsy samples and the limitations of proteomic technologies compared to high-plex sequencing technologies have hindered the development of proteomics. However, novel protein technologies are urgently needed for biomarker discovery in cancer liquid biopsies. Traditional and innovative proteomic technologies are being rapidly developed and have greatly facilitated early detection, diagnosis, prognosis, and monitoring of cancer evolution.

MOLECULAR CANCER (2022)

Review Biochemistry & Molecular Biology

The diversity of lipocalin receptors

Bernhard Redl et al.

Summary: Lipocalins are crucial carriers of hydrophobic molecules and play a role in various physiological processes in different species. They interact with cell receptors to exert their biological effects. Recent research has revealed new findings on the molecules involved in cellular uptake or signaling effects of lipocalins.

BIOCHIMIE (2022)

Article Gastroenterology & Hepatology

Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures

Maria Arechederra et al.

Summary: The NGS mutational analysis of bile cfDNA, named Bilemut, showed a sensitivity of 96.4% and specificity of 69.2% for detecting malignancy in patients with suspicious biliary strictures. Implementation of Bilemut at the initial diagnostic stage can significantly improve detection of malignancy, reduce delays in clinical management, and assist in selecting patients for targeted therapies.
Article Gastroenterology & Hepatology

Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bile

Hege Marie Vedeld et al.

Summary: The study aimed to establish robust DNA methylation biomarkers in bile for early and accurate diagnosis of CCA in PSC. Using ddPCR analysis, high accuracy was achieved in detecting CCA in PSC patients, even up to 12 months before official diagnosis, indicating the potential of these biomarkers to complement current detection methods.

HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Bile multi-omics analysis classifies lipid species and microbial peptides predictive of carcinoma of gallbladder

Nupur Sharma et al.

Summary: The study found that there is a significant decrease in lipid species and an increase in bacterial taxa in bile samples of patients with gallbladder carcinoma (CAGB), which suggests that these features could be used for early diagnosis of CAGB.

HEPATOLOGY (2022)

Review Biochemistry & Molecular Biology

Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments

Saife N. Lone et al.

Summary: Liquid biopsies are non-invasive methods that have revolutionized cancer diagnosis and monitoring. By analyzing tumor-derived entities in body fluids, liquid biopsies provide detailed information about tumor characteristics and can be used for detection, prognosis, and treatment monitoring.

MOLECULAR CANCER (2022)

Review Oncology

Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges

Blanca Trujillo et al.

Summary: Liquid biopsy is a powerful tool for detecting cancer aberrations in real-time, especially in prostate cancer. However, there are still challenges in screening, risk stratification, and treatment of advanced disease. Therefore, developing better biomarkers is urgently needed to guide oncologists' decisions.

BRITISH JOURNAL OF CANCER (2022)

Review Oncology

Circulating tumour DNA - looking beyond the blood

Ann Tivey et al.

Summary: Over the past decade, liquid biopsy techniques have emerged as alternatives to traditional tissue biopsy samples. Majority of research in this field has focused on blood-based biomarkers, especially circulating tumor DNA (ctDNA) derived from plasma. However, ctDNA can also be obtained from non-blood sources such as urine, cerebrospinal fluid, and pleural or peritoneal fluid. In this review, the authors discuss the advances in analyzing ctDNA from non-blood sources, exploring the distinct advantages and technical aspects of non-blood ctDNA assay development. They also reflect on when non-blood ctDNA can have advantages over plasma ctDNA and the challenges of translating these assays into clinical use.

NATURE REVIEWS CLINICAL ONCOLOGY (2022)

Review Chemistry, Multidisciplinary

Multi-omics analysis revealed the role of extracellular vesicles in hepatobiliary & pancreatic tumor

Xiangdong Gongye et al.

Summary: Liquid biopsy is a rapidly growing research field known for its minimal invasiveness. Extracellular vesicles (EVs), as newly discovered active substance carriers, are expected to play a significant role in diagnostic technology. This article summarizes the recent developments in various omics analysis of EVs and explores their potential role in the early diagnosis of hepatobiliary and pancreatic tumors through multi-omics analysis.

JOURNAL OF CONTROLLED RELEASE (2022)

Review Oncology

Liquid biopsy: current technology and clinical applications

Mina Nikanjam et al.

Summary: Liquid biopsies, including circulating extracellular nucleic acids (cfDNA and ctDNA) and circulating tumor cells (CTCs), have important clinical applications in precision oncology, such as predicting treatment response and resistance, analyzing prognosis and tumor burden, and detecting cancer at early stages. This review provides an overview of current technologies and clinical applications for liquid biopsies, highlighting the potential of this powerful tool in multiple aspects of cancer management.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)

Review Immunology

Research progress of bile biomarkers and their immunoregulatory role in biliary tract cancers

Yun-cheng Li et al.

Summary: Biliary tract cancers, including cholangiocarcinoma and gallbladder carcinoma, originate from the biliary epithelium and have a poor prognosis. Surgery is the only choice for cure in the early stage of disease, and early diagnosis could significantly improve the prognosis of patients. Bile components are closely related to the occurrence and development of biliary tract tumors and may be applied as biomarkers for BTCs.

FRONTIERS IN IMMUNOLOGY (2022)

Article Oncology

Bile-derived exosome noncoding RNAs as potential diagnostic and prognostic biomarkers for cholangiocarcinoma

Yan Pan et al.

Summary: This study found that specific bile-derived noncoding RNAs (ncRNAs) can serve as biomarkers for early diagnosis and prognosis of cholangiocarcinoma (CCA). In particular, bile exosomal miR-200c-3p showed good diagnostic value, while high levels of bile exosomal miR-200a-3p, miR-200c-3p, and serum exosomal miR-200c-3p were associated with adverse clinical outcomes.

FRONTIERS IN ONCOLOGY (2022)

Review Medical Laboratory Technology

Liquid Biopsy in Breast Cancer

Timothy Kwang Yong Tay et al.

Summary: Liquid biopsies have shown promising results in breast cancer, particularly in monitoring treatment response and predicting disease progression or relapse. With further research and advancements in technology, liquid biopsies may have a greater role in the breast cancer clinic in the future.

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2021)

Article Gastroenterology & Hepatology

A Circular RNA, Cholangiocarcinoma-Associated Circular RNA 1, Contributes to Cholangiocarcinoma Progression, Induces Angiogenesis, and Disrupts Vascular Endothelial Barriers

Yi Xu et al.

Summary: The study revealed that circ-CCAC1 is upregulated in cholangiocarcinoma (CCA) cells and extracellular vesicles (EVs), and plays a crucial role in promoting CCA tumorigenesis and metastasis through various mechanisms.

HEPATOLOGY (2021)

Article Biophysics

Calibration-free analysis of surface proteins on single extracellular vesicles enabled by DNA nanostructure

Kaizhu Guo et al.

Summary: The ultrasensitive method reported in this study can detect single EVs with an input as low as 100 vesicles/µL by using DNA nanostructure labeling and EV membrane staining. It allows calibration-free analysis of protein profiles among different EV samples, differentiation of EVs by their cell of origin, and co-localization of dual protein markers on the same EV. The method shows great potential for non-invasive detection of EV-based protein biomarkers for cancer diagnosis and treatment monitoring.

BIOSENSORS & BIOELECTRONICS (2021)

Article Medical Laboratory Technology

Circulating Cell-Free DNA Yield and Circulating-Tumor DNA Quantity from Liquid Biopsies of 12 139 Cancer Patients

Richard S. P. Huang et al.

Summary: The study reveals that the amount of ctDNA in liquid biopsies varies significantly depending on patient age, sex, stage, and tumor type, which may explain why some liquid biopsy specimens are more likely to fail sequencing. Additionally, patients with higher levels of ctDNA have a higher success rate in issuing clinically useful reports.

CLINICAL CHEMISTRY (2021)

Article Biochemical Research Methods

Digging deeper into bile proteome

Sergio Ciordia et al.

Summary: The analysis of biological fluids for disease-related proteins is an important field of research. However, challenges exist, especially in complex matrices like bile. A new procedure described in this study significantly improves protein recovery from rat bile, providing valuable resources for further understanding disease molecular markers.

JOURNAL OF PROTEOMICS (2021)

Article Oncology

Liquid biopsy enters the clinic - implementation issues and future challenges

Michail Ignatiadis et al.

Summary: The approval of liquid biopsy assays for detecting genetic alterations in plasma cell-free DNA has marked a tipping point for the clinical use of this technology, especially in patients with advanced-stage cancer. The next frontier is likely to be the systemic treatment of patients with 'ctDNA relapse' and other potential future applications include cancer screening and diagnosis.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Article Multidisciplinary Sciences

Utility of Claudin-3 in extracellular vesicles from human bile as biomarkers of cholangiocarcinoma

Chisaki Ikeda et al.

Summary: This study isolated EVs from human bile using EDEG and performed proteomic analysis, identifying Claudin-3 as a useful biomarker for CCA. The diagnostic accuracy was high with AUC 0.945 and sensitivity and specificity of 87.5%.

SCIENTIFIC REPORTS (2021)

Review Biotechnology & Applied Microbiology

Roles of Bile-Derived Exosomes in Hepatobiliary Disease

Yuan Yao et al.

Summary: This review provides a comprehensive summary of bile-derived exosomes, focusing on their isolation methods and the roles of exosomal noncoding RNAs in physiological and disease states. It also discusses the potential clinical applications of bile-derived exosomes.

BIOMED RESEARCH INTERNATIONAL (2021)

Review Oncology

Exosome-based liquid biopsies in cancer: opportunities and challenges

W. Yu et al.

Summary: Liquid biopsy in cancer research has seen significant progress, with efforts focused on utilizing circulating tumor cells, circulating tumor DNA, and extracellular vesicles like exosomes. Exosomes, as part of the intercellular communication system, carry tumor-derived materials and can serve as stable biomarkers for early detection and monitoring of cancer.

ANNALS OF ONCOLOGY (2021)

Review Oncology

Cholangiocarcinoma Therapeutics: An Update

Mai Ly Thi Nguyen et al.

Summary: This review compares the treatment outcomes of different therapeutics for cholangiocarcinoma based on overall survival and progression-free survival. Early stage CCAs should undergo tumor resection surgery followed by postoperative treatment with Capecitabine, while chemotherapy can be considered for unresectable CCAs. Inoperable CCAs with genetic alterations may benefit from targeted therapies, and specific triplet chemotherapy regimens show promise for advanced cases of CCA.

CURRENT CANCER DRUG TARGETS (2021)

Review Gastroenterology & Hepatology

Bile formation and secretion: An update

James Lorenzen Boyer et al.

Summary: Bile formation is a crucial physiological process for the survival of vertebrates, with its mechanisms gradually understood after World War II. From classic physiologic studies in animal models and humans to research in isolated cells and membrane vesicles, the identification of specific transport systems has been key to understanding this secretion. Progress in this field was reviewed in 2013, and this update provides further insights into advancements made since then.

JOURNAL OF HEPATOLOGY (2021)

Article Medicine, General & Internal

The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma

Monika Lewinska et al.

Summary: The study revealed a complete rearrangement of the serum lipidome in NAFLD-HCC patients, allowing for efficient differentiation from healthy individuals and other HCC patients. A diagnostic model for NAFLD-HCC was developed with superior diagnostic potential compared to traditional AFP. These findings contribute to early detection of NAFLD-HCC.

EBIOMEDICINE (2021)

Article Medicine, General & Internal

Vimentin-Positive Circulating Tumor Cells as Diagnostic and Prognostic Biomarkers in Patients with Biliary Tract Cancer

Sung Yong Han et al.

Summary: The study evaluated the diagnostic efficacy and prognostic value of vimentin-positive circulating tumor cells (V-CTCs) in patients with biliary tract cancer (BTC). Results showed significant differences in V-CTC count and ratio between BTC and benign biliary disease (BBD), and combining these parameters improved accuracy. V-CTC count > 50/mL blood was a significant factor affecting survival, suggesting its potential as a biomarker for early diagnosis and prognosis prediction in BTC patients.

JOURNAL OF CLINICAL MEDICINE (2021)

Review Oncology

Biliary Strictures and Cholangiocarcinoma - Untangling a Diagnostic Conundrum

Alexander Ney et al.

Summary: Cholangiocarcinoma is a rare and highly aggressive biliary tract malignancy that is difficult to diagnose early. Standard serum markers lack sensitivity and specificity, driving the search for novel biomarkers for screening and early detection. However, clinical translation of these biomarkers is slow and further validation in larger patient cohorts is needed.

FRONTIERS IN ONCOLOGY (2021)

Review Oncology

Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology

Ashish Manne et al.

Summary: Recent advancements in precision medicine have made it possible to identify new molecular markers for BTCs, including epigenetic changes and non-DNA markers, providing hope for improved diagnosis and treatment outcomes.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

Cell-free DNA from bile outperformed plasma as a potential alternative to tissue biopsy in biliary tract cancer

Q. Gou et al.

Summary: The study demonstrated that bile cell-free DNA (cfDNA) was superior to plasma cfDNA in detecting tumor-related genomic alterations. The sensitivity of CA 19-9 combined with bile cfDNA reached 96.4% in BTC diagnosis, suggesting that bile cfDNA could be a supplemental approach for confirming BTC diagnosis.

ESMO OPEN (2021)

Review Oncology

Liquid Biopsy: From Discovery to Clinical Application

Catherine Alix-Panabieres et al.

Summary: CTC and ctDNA have been recognized as promising biomarkers with various clinical applications, including early cancer detection and therapeutic monitoring. However, challenges such as standardization and validation of clinical effectiveness need to be addressed in this dynamic field of translational cancer research.

CANCER DISCOVERY (2021)

Article Multidisciplinary Sciences

Co-continuous structural effect of size-controlled macro-porous glass membrane on extracellular vesicle collection for the analysis of miRNA

Hiroshi Yukawa et al.

Summary: Recent studies have shown that extracellular vesicles (EVs) can be used as biomarkers for the diagnosis and prognosis of serious illnesses. A new AGC device with a size-controlled macro-porous glass (MPG) membrane has been developed to collect EVs and efficiently extract miRNA from them in various body fluids.

SCIENTIFIC REPORTS (2021)

Review Medicine, General & Internal

The Emerging Role of Liquid Biopsy in Gastric Cancer

Csongor Gyorgy Lengyel et al.

Summary: Liquid biopsy shows promising clinical applications in metastatic gastric cancer, providing important prognostic information and guiding treatment choices. Detection of circulating tumor cells has prognostic value in all disease stages, while circulating DNA and exosomes can assess cancer recurrence and metastatic risk.

JOURNAL OF CLINICAL MEDICINE (2021)

Review Cell Biology

Emerging methods in biomarker identification for extracellular vesicle-based liquid biopsy

Yaxuan Liang et al.

Summary: EVs are released by various cell types and carry unique molecular information. The heterogeneity in EV populations poses challenges for researchers, but also allows for predicting disease pathogenesis. Advanced methods are needed for EV purification and evaluation from complex biofluids.

JOURNAL OF EXTRACELLULAR VESICLES (2021)

Article Public, Environmental & Occupational Health

Global, regional, and national quality of care of gallbladder and biliary tract cancer: a systematic analysis for the global burden of disease study 1990-2017

Javad Khanali et al.

Summary: The study implemented the novel Quality of Care Index (QCI) to estimate the quality and accessibility of care for patients with gallbladder and biliary tract cancer. Results showed significant improvement in QCI from 1990 to 2017, with heterogeneous distribution and inequity across regions, countries, gender, and age groups.

INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH (2021)

Article Biochemical Research Methods

DISMIR: Deep learning-based noninvasive cancer detection by integrating DNA sequence and methylation information of individual cell-free DNA reads

Jiaqi Li et al.

Summary: The novel approach DISMIR integrates DNA sequence and methylation information in plasma cfDNA WGBS data to provide highly sensitive and robust cancer detection, exhibiting high accuracy and potential for hepatocellular carcinoma detection. It is resistant to technical noise and tends to be insensitive to alterations of single CpG sites' methylation states, making it a precise and low-cost method for early cancer detection.

BRIEFINGS IN BIOINFORMATICS (2021)

Article Gastroenterology & Hepatology

The diagnostic value of exosomal miRNAs in human bile of malignant biliary obstructions

Xianxiu Ge et al.

Summary: The study aimed to investigate the potential role of exosomes in diagnosing malignant biliary obstructions. mir-483-5p and mir-126-3t were found to be up-regulated in bile exosomes from patients with malignant biliary obstructions, providing effective differentiation between malignant and nonmalignant biliary obstructions.

DIGESTIVE AND LIVER DISEASE (2021)

Article Gastroenterology & Hepatology

Bile extracellular vesicles from end-stage liver disease patients show altered microRNA content

Suguru Nakashiki et al.

Summary: EVs, particularly bile EVs, show potential as novel biomarkers for liver diseases, with higher concentrations observed in recipients with liver failure, particularly those with hepatocellular carcinoma. The miRNA content in bile EVs increases in the ESLD state, and these miRNA levels are not correlated with those in serum EVs, indicating their promise as diagnostic tools.

HEPATOLOGY INTERNATIONAL (2021)

Review Medicine, General & Internal

The Role of K-Ras and P53 in Biliary Tract Carcinoma

Saara Ahmad et al.

Summary: The study found that mutations in both K-Ras and p53 genes are associated with biliary tract carcinoma, with K-Ras mutation having a higher frequency compared to p53 inactivation in such cancers.

JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION (2021)

Review Biochemistry & Molecular Biology

Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer

Misako Nagasaka et al.

Summary: Liquid biopsy has become a valuable diagnostic tool for advanced NSCLC, with ctDNA analysis being a key method for identifying targetable mutations. Monitoring ctDNA in plasma can help assess treatment response and residual disease burden, and new methods like miRNA and lncRNA are also being explored for their potential in NSCLC diagnosis and monitoring.

MOLECULAR CANCER (2021)

Article Multidisciplinary Sciences

Soluble cluster of differentiation 14 levels elevated in bile from gallbladder cancer cases from Shanghai, China

Victoria L. Brun et al.

Summary: Elevated levels of sCD14 in bile are associated with gallbladder cancer, but this association is influenced by inflammation. Early findings suggest a potential role of sCD14 in the pathogenesis of GBC.

SCIENTIFIC REPORTS (2021)

Review Oncology

Assessment of Circulating Nucleic Acids in Cancer: From Current Status to Future Perspectives and Potential Clinical Applications

Gabriella Cirmena et al.

Summary: Liquid biopsy, which aims to identify tumor biomarkers through noninvasive analysis of body fluids, is a promising approach for cancer screening, but its clinical applications are currently limited due to the lack of standardized pre-analytical procedures and technical challenges.

CANCERS (2021)

Article Oncology

Liquid Biopsy from Bile-Circulating Tumor DNA in Patients with Biliary Tract Cancer

Jin-Yi Han et al.

Summary: Utilization of cell free DNA from bile fluid shows promising potential for diagnosing and monitoring patients with biliary tract cancers, with mutational variants reliably detected and showing a strong positive correlation with tissue samples, suggesting bile as an effective biopsy fluid for ctDNA analysis.

CANCERS (2021)

Review Oncology

Prostate Cancer Liquid Biopsy Biomarkers' Clinical Utility in Diagnosis and Prognosis

Milena Matuszczak et al.

Summary: In prostate cancer, overdiagnosis and overtreatment are common problems. New liquid biopsy biomarker tests have been developed to improve diagnosis, prognosis, and decision-making. The current gold standard for diagnosing prostate cancer relies on digital rectal examination and elevated prostate-specific antigen levels before biopsy.

CANCERS (2021)

Review Biochemistry & Molecular Biology

Clinical Utility of Liquid Biopsy-Based Actionable Mutations Detected via ddPCR

Irina Palacin-Aliana et al.

Summary: Cancer remains a major public health challenge worldwide, and molecular pathology profiling is fundamental for tumor diagnosis and therapeutic decisions. Liquid biopsies show potential as a tool for detecting cancer-specific biomarkers, providing information about tumor dynamics.

BIOMEDICINES (2021)

Review Biochemistry & Molecular Biology

Circulating tumor cells: biology and clinical significance

Danfeng Lin et al.

Summary: CTCs, tumor cells that have sloughed off the primary tumor and circulate in the blood, have potential for identifying targets against cancer metastasis. Detecting these rare CTCs in the massive pool of blood cells is challenging, but emerging detection technologies have deepened our understanding of their biology and clinical applications. Molecular markers, such as epithelial cell adhesion molecule, play a key role in CTC detection, with properties like epithelial-to-mesenchymal transition and stemness indicating increased metastatic capacity.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Article Gastroenterology & Hepatology

Bile-derived circulating extracellular miR-30d-5p and miR-92a-3p as potential biomarkers for cholangiocarcinoma

Hye Sook Han et al.

HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2020)

Article Cell Biology

Extracellular vesicles as biomarkers and therapeutic targets for cancer

Fumihiko Urabe et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2020)

Review Biochemistry & Molecular Biology

Circulating tumor cells in cancer patients: developments and clinical applications for immunotherapy

Xiaoming Zhong et al.

MOLECULAR CANCER (2020)

Review Genetics & Heredity

Tracking cancer progression: from circulating tumor cells to metastasis

Francesc Castro-Giner et al.

GENOME MEDICINE (2020)

Review Biochemistry & Molecular Biology

Biological Functions and Therapeutic Potential of Lipocalin 2 in Cancer

Ginette S. Santiago-Sanchez et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Multidisciplinary Sciences

Evaluating the quantity, quality and size distribution of cell-free DNA by multiplex droplet digital PCR

Miguel Alcaide et al.

SCIENTIFIC REPORTS (2020)

Review Biochemistry & Molecular Biology

Technical and Methodological Aspects of Cell-Free Nucleic Acids Analyzes

Zuzana Pos et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Oncology

Isolation and characterization of exosomes for cancer research

Le Zhu et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

Review Oncology

ctDNA as a cancer biomarker: A broad overview

Luciana Santos Pessoa et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)

Review Oncology

Circulating Tumor DNA in Biliary Tract Cancer: Current Evidence and Future Perspectives

Alessandro Rizzo et al.

CANCER GENOMICS & PROTEOMICS (2020)

Review Oncology

Circulating tumor DNA and liquid biopsy in oncology

David W. Cescon et al.

NATURE CANCER (2020)

Article Medical Laboratory Technology

Bile cytology: A new scoring system for improving diagnostic accuracy

Chie Hayakawa et al.

DIAGNOSTIC CYTOPATHOLOGY (2019)

Review Biochemistry & Molecular Biology

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA

Qianwei Ye et al.

MOLECULAR CANCER (2019)

Article Oncology

Connections between metabolism and epigenetics in cancers

Chitra Thakur et al.

SEMINARS IN CANCER BIOLOGY (2019)

Review Oncology

Cell free circulating tumor nucleic acids, a revolution in personalized cancer medicine

Mohammad Amin Kerachian et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)

Review Genetics & Heredity

Current and future perspectives of liquid biopsies in genomics-driven oncology

Ellen Heitzer et al.

NATURE REVIEWS GENETICS (2019)

Review Gastroenterology & Hepatology

Noncoding RNA in Cholangiocarcinoma

Massimiliano Salati et al.

SEMINARS IN LIVER DISEASE (2019)

Review Biochemistry & Molecular Biology

Exploiting the message from cancer: the diagnostic value of extracellular vesicles for clinical applications

Nobuyoshi Kosaka et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2019)

Review Chemistry, Multidisciplinary

Exosome Biochemistry and Advanced Nanotechnology for Next-Generation Theranostic Platforms

Bowen Yang et al.

ADVANCED MATERIALS (2019)

Review Pharmacology & Pharmacy

Clinical applications of the CellSearch platform in cancer patients

Sabine Riethdorf et al.

ADVANCED DRUG DELIVERY REVIEWS (2018)

Article Oncology

Liquid biopsy of bile for the molecular diagnosis of gallbladder cancer

Hideaki Kinugasa et al.

CANCER BIOLOGY & THERAPY (2018)

Review Cell Biology

Shedding light on the cell biology of extracellular vesicles

Guillaume van Niel et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)

Article Cell Biology

Immunoaffinity-based isolation of melanoma cell-derived exosomes from plasma of patients with melanoma

Priyanka Sharma et al.

JOURNAL OF EXTRACELLULAR VESICLES (2018)

Article Oncology

Quantification of Circulating Free DNA as a Diagnostic Marker in Gall Bladder Cancer

Swati Kumari et al.

PATHOLOGY & ONCOLOGY RESEARCH (2017)

Article Gastroenterology & Hepatology

Extracellular Vesicles in Bile as Markers of Malignant Biliary Stenoses

Valeria Severino et al.

GASTROENTEROLOGY (2017)

Review Oncology

New Horizons for Precision Medicine in Biliary Tract Cancers

Juan W. Valle et al.

CANCER DISCOVERY (2017)

Article Multidisciplinary Sciences

A Microfluidic Chip for Detecting Cholangiocarcinoma Cells in Human Bile

Lien-Yu Hung et al.

SCIENTIFIC REPORTS (2017)

Review Oncology

Liquid biopsies come of age: towards implementation of circulating tumour DNA

Jonathan C. M. Wan et al.

NATURE REVIEWS CANCER (2017)

Review Biochemistry & Molecular Biology

Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers

Pablo Letelier et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)

Letter Gastroenterology & Hepatology

MicroRNAs in Bile Vesicles: Finding a Trade-off for Biomarker Discovery

Henk P. Roest et al.

HEPATOLOGY (2015)

Article Multidisciplinary Sciences

MicroRNAs in Serum and Bile of Patients with Primary Sclerosing Cholangitis and/or Cholangiocarcinoma

Torsten Voigtlaender et al.

PLOS ONE (2015)

Article Oncology

Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas

Oliver A. Zill et al.

CANCER DISCOVERY (2015)

Review Medical Laboratory Technology

Circulating Tumor DNA as a Liquid Biopsy for Cancer

Ellen Heitzer et al.

CLINICAL CHEMISTRY (2015)

Article Biochemical Research Methods

Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification

Alison S. Devonshire et al.

ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2014)

Article Biochemistry & Molecular Biology

Bile carcinoembryonic cell adhesion molecule 6 (CEAM6) as a biomarker of malignant biliary stenoses

Annarita Farina et al.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2014)

Article Gastroenterology & Hepatology

Factors affecting the accuracy of endoscopic transpapillary sampling methods for bile duct cancer

Takao Nishikawa et al.

DIGESTIVE ENDOSCOPY (2014)

Editorial Material Gastroenterology & Hepatology

Endoscopic tissue sampling of the bile duct: Can we do better?

Isaac Raijman

DIGESTIVE ENDOSCOPY (2014)

Review Chemistry, Analytical

Metabolomics in cancer biomarker discovery: Current trends and future perspectives

Emily G. Armitage et al.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2014)

Article Multidisciplinary Sciences

Mutational landscape of intrahepatic cholangiocarcinoma

Shanshan Zou et al.

NATURE COMMUNICATIONS (2014)

Article Physiology

Bile Proteome in Health and Disease

Annarita Farina et al.

COMPREHENSIVE PHYSIOLOGY (2014)

Article Gastroenterology & Hepatology

Different Expression of S100A8 in Malignant and Benign Gallbladder Diseases

Wei Wang et al.

DIGESTIVE DISEASES AND SCIENCES (2013)

Article Gastroenterology & Hepatology

Vascular Endothelial Growth Factor Levels in Bile Distinguishes Pancreatic Cancer from Other Etiologies of Biliary Stricture: A Pilot Study

Udayakumar Navaneethan et al.

DIGESTIVE DISEASES AND SCIENCES (2013)

Article Gastroenterology & Hepatology

Clinicopathological significance of S100 protein expression in cholangiocarcinoma

Yasunori Sato et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)

Review Gastroenterology & Hepatology

Physiological and molecular biochemical mechanisms of bile formation

Vasiliy Ivanovich Reshetnyak

WORLD JOURNAL OF GASTROENTEROLOGY (2013)

Article Physiology

Bile Formation and Secretion

James L. Boyer

COMPREHENSIVE PHYSIOLOGY (2013)

Review Biochemistry & Molecular Biology

Pro-Inflammatory S100A8 and S100A9 Proteins: Self-Assembly into Multifunctional Native and Amyloid Complexes

Thomas Vogl et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)

Article Gastroenterology & Hepatology

Bile aspiration cytology in diagnosis of bile duct carcinoma: factors associated with positive yields

Yasser A. Abdelghani et al.

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2012)

Article Multidisciplinary Sciences

S100A9 is a Biliary Protein Marker of Disease Activity in Primary Sclerosing Cholangitis

Lisa Reinhard et al.

PLOS ONE (2012)

Article Gastroenterology & Hepatology

Elevated Levels of Neutrophil Gelatinase-Associated Lipocalin in Bile From Patients With Malignant Pancreatobiliary Disease

Abigail A. Zabron et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)

Article Gastroenterology & Hepatology

Clinical significance of bile cytology via an endoscopic nasobiliary drainage tube for pathological diagnosis of malignant biliary strictures

Hiroshi Yagioka et al.

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2011)

Article Biochemical Research Methods

A Step Further in the Analysis of Human Bile Proteome

Annarita Farina et al.

JOURNAL OF PROTEOME RESEARCH (2011)

Article Biochemical Research Methods

Comprehensive proteomic analysis of human bile

Mustafa A. Barbhuiya et al.

PROTEOMICS (2011)

Review Medicine, Research & Experimental

Human bile as a rich source of biomarkers for hepatopancreatobiliary cancers

G. A. Nagana Gowda

BIOMARKERS IN MEDICINE (2010)

Review Biochemical Research Methods

Proteomic analysis of human bile and potential applications for cancer diagnosis

Annarita Farina et al.

EXPERT REVIEW OF PROTEOMICS (2009)

Article Oncology

MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer

W. R. Matull et al.

BRITISH JOURNAL OF CANCER (2008)

Review Gastroenterology & Hepatology

Physiology of bile secretion

Alejandro Esteller

WORLD JOURNAL OF GASTROENTEROLOGY (2008)

Article Biochemical Research Methods

A proteomic analysis of human bile

TZ Kristiansen et al.

MOLECULAR & CELLULAR PROTEOMICS (2004)

Article Medicine, General & Internal

Low frequency of p53 and ras mutations in bile of patients with hepato-biliary disease:: a prospective study in more than 100 patients

P Müller et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2001)

Article Gastroenterology & Hepatology

K-ras mutations in the bile of patients with primary sclerosing cholangitis

S Kubicka et al.